bethanidine has been researched along with Arrhythmia in 6 studies
Bethanidine: A guanidinium antihypertensive agent that acts by blocking adrenergic transmission. The precise mode of action is not clear.
Excerpt | Relevance | Reference |
---|---|---|
"In all cases, arrhythmias were preceded by and appeared to be temporally related to progressive fractionation and delay of electrograms recorded from the ischemic zone." | 5.28 | Ischemia-induced conduction delay and ventricular arrhythmias: comparative electropharmacology of bethanidine sulfate and bretylium tosylate. ( Kabell, G, 1989) |
"Bethanidine sulfate is a chemical and pharmacologic analog of bretylium tosylate that has virtually identical antifibrillatory and inotropic actions on the heart." | 5.26 | Antiarrhythmic, antifibrillatory, and hemodynamic actions of bethanidine sulfate: an orally effective analog of bretylium for suppression of ventricular tachyarrhythmias. ( Bacaner, MB; Benditt, DG, 1982) |
" Serious adverse reactions necessitate a change in antiarrhythmic therapy, as opposed to lowering drug dosage to an ineffective level." | 2.37 | Antiarrhythmic drug therapy. Recent advances and current status. ( Somberg, J, 1985) |
"In all cases, arrhythmias were preceded by and appeared to be temporally related to progressive fractionation and delay of electrograms recorded from the ischemic zone." | 1.28 | Ischemia-induced conduction delay and ventricular arrhythmias: comparative electropharmacology of bethanidine sulfate and bretylium tosylate. ( Kabell, G, 1989) |
"These arrhythmias occurred during the period of occlusion and even more prominently after release of the occlusion." | 1.27 | A comparison of the effects of bethanidine, meobentine and quinidine on the electrical activity of rat hearts in vivo and in vitro. ( Northover, BJ, 1985) |
"Bethanidine sulfate is a chemical and pharmacologic analog of bretylium tosylate that has virtually identical antifibrillatory and inotropic actions on the heart." | 1.26 | Antiarrhythmic, antifibrillatory, and hemodynamic actions of bethanidine sulfate: an orally effective analog of bretylium for suppression of ventricular tachyarrhythmias. ( Bacaner, MB; Benditt, DG, 1982) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Houston, MC | 1 |
Bacaner, MB | 1 |
Benditt, DG | 1 |
Lawson, DH | 1 |
Hutcheon, AW | 1 |
Jick, H | 1 |
Kabell, G | 1 |
Somberg, J | 1 |
Northover, BJ | 1 |
2 reviews available for bethanidine and Arrhythmia
Article | Year |
---|---|
Abrupt cessation of treatment in hypertension: consideration of clinical features, mechanisms, prevention and management of the discontinuation syndrome.
Topics: Acute Disease; Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Bethanidine; Blood Pressure; Cloni | 1981 |
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrh | 1985 |
4 other studies available for bethanidine and Arrhythmia
Article | Year |
---|---|
Antiarrhythmic, antifibrillatory, and hemodynamic actions of bethanidine sulfate: an orally effective analog of bretylium for suppression of ventricular tachyarrhythmias.
Topics: Adult; Aged; Arrhythmias, Cardiac; Bethanidine; Bretylium Tosylate; Depression, Chemical; Dose-Respo | 1982 |
Life threatening drug reactions amongst medical in-patients.
Topics: Aged; Arrhythmias, Cardiac; Bethanidine; Digoxin; Drug-Related Side Effects and Adverse Reactions; F | 1979 |
Ischemia-induced conduction delay and ventricular arrhythmias: comparative electropharmacology of bethanidine sulfate and bretylium tosylate.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Bethanidine; Bretylium Compounds; Bretylium Tosyla | 1989 |
A comparison of the effects of bethanidine, meobentine and quinidine on the electrical activity of rat hearts in vivo and in vitro.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bethanidine; Coronary Dise | 1985 |